Alivus Life Sciences Limited — Important, 30-05-2025: General Updates
30-05-2025 | 11:22 am
30-05-2025 | 11:22 am
Alivus Life Sciences has announced a board meeting to approve the financial results for the quarter and half-year. Its Dahej API manufacturing facility cleared a USFDA GMP inspection with zero observations, underscoring strong compliance and operational quality. This boosts confidence in the company’s manufacturing excellence and could enhance its competitive edge in regulated markets.
No comments yet. Be the first to comment!
